z-logo
open-access-imgOpen Access
Fighting the uphill battle to cure type 1 diabetes
Author(s) -
Lee Eun Young,
Yoon KunHo
Publication year - 2021
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13613
Subject(s) - medicine , type 1 diabetes , beta cell , diabetes mellitus , islet , type 2 diabetes , beta (programming language) , insulin , artificial pancreas , immunotherapy , immune system , immunology , bioinformatics , endocrinology , computer science , biology , programming language
Three complementary approaches for type 1 diabetes. Immunotherapy targets the pathogenic immune cells or inflammatory cytokines to revert type 1 diabetes. An artificial pancreas delivers insulin automatically using continuous glucose monitoring, a controlling algorithm, and an insulin pump. Beta cell replacement therapy varies depending on the cell sources: allogeneic, or xenogeneic islet; beta‐like cells derived from ESCs or iPSCs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here